Prevalence of Human Brucellosis in Ethiopia: Systematic Review and Meta-analysis

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2025 Mar 16

PMID 40089675

Authors

Fikir Asrie

Mastewal Birhan

Mulat Dagnew

Nega Berhane

Affiliations

Soon will be listed here.

Abstract

Brucellosis is a significant public health challenge in Ethiopia, which is characterized by a high prevalence among humans. The disease is primarily transmitted through the consumption of unpasteurized dairy products, direct contact with infected animals, or inhalation of contaminated aerosols. In addition to its impact on human health, brucellosis imposes substantial economic burdens. However, existing epidemiological studies provide inconsistent prevalence estimates, underscoring the need for a more comprehensive and systematic analysis of the disease's burden and associated risk factors in Ethiopia. This systematic review and meta-analysis aimed to generate representative data on the prevalence of human brucellosis in Ethiopia. We searched databases like PubMed and Science Direct for articles published between 2007 and 2022. The analysis included 26 studies covering 5,718 human serum samples. The Complement Fixation Test served as the confirmatory diagnostic test. The results suggest a relatively high seroprevalence of human brucellosis in Ethiopia, with an overall pooled prevalence of 14.0% (95% CI: 10.23, 18.12). Prevalence varied significantly across regions, with the highest observed in Afar (24.21%) and the lowest in Oromia (7.75%). Substantial heterogeneity was observed (I² = 97.64%), suggesting significant variations in prevalence across regions and over time. Additionally, the analysis suggests a possible increasing trend in prevalence over the years. Human brucellosis is a significant health concern in Ethiopia, and further research is crucial for effective prevention and control. The higher prevalence than previously reported in meta-analyses underscores the urgent need for intervention strategies from policymakers, such as the Ministry of Health. Identifying risk factors associated with human brucellosis is essential for implementing effective control measures. Prioritizing brucellosis prevention and control is vital for ensuring public health and well-being. Prospero registration number: CRD42022350237.

References

Pereira C, Cotrim de Almeida J, Cardoso de Oliveira I, de Oliveira L, Pereira L, Zangeronimo M . Occupational exposure to Brucella spp.: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020; 14(5):e0008164. PMC: 7252629. DOI: 10.1371/journal.pntd.0008164. View

Tadesse G . Brucellosis Seropositivity in Animals and Humans in Ethiopia: A Meta-analysis. PLoS Negl Trop Dis. 2016; 10(10):e0005006. PMC: 5085315. DOI: 10.1371/journal.pntd.0005006. View

Ibrahim M, Schelling E, Zinsstag J, Hattendorf J, Andargie E, Tschopp R . Sero-prevalence of brucellosis, Q-fever and Rift Valley fever in humans and livestock in Somali Region, Ethiopia. PLoS Negl Trop Dis. 2021; 15(1):e0008100. PMC: 7861547. DOI: 10.1371/journal.pntd.0008100. View

Tschopp R, Gebregiorgis A, Tassachew Y, Andualem H, Osman M, Waqjira M . Integrated human-animal sero-surveillance of Brucellosis in the pastoral Afar and Somali regions of Ethiopia. PLoS Negl Trop Dis. 2021; 15(8):e0009593. PMC: 8372887. DOI: 10.1371/journal.pntd.0009593. View

Workalemahu B, Sewunet T, Astatkie A . Seroepidemiology of Human Brucellosis Among Blood Donors in Southern Ethiopia: Calling Attention to a Neglected Zoonotic Disease. Am J Trop Med Hyg. 2017; 96(1):88-92. PMC: 5239715. DOI: 10.4269/ajtmh.15-0702. View

Edao B, Ameni G, Assefa Z, Berg S, Whatmore A, Wood J . Brucellosis in ruminants and pastoralists in Borena, Southern Ethiopia. PLoS Negl Trop Dis. 2020; 14(7):e0008461. PMC: 7406081. DOI: 10.1371/journal.pntd.0008461. View

Zerfu B, Medhin G, Mamo G, Getahun G, Tschopp R, Legesse M . Community-based prevalence of typhoid fever, typhus, brucellosis and malaria among symptomatic individuals in Afar Region, Ethiopia. PLoS Negl Trop Dis. 2018; 12(10):e0006749. PMC: 6191156. DOI: 10.1371/journal.pntd.0006749. View

Porritt K, Gomersall J, Lockwood C . JBI's Systematic Reviews: Study selection and critical appraisal. Am J Nurs. 2014; 114(6):47-52. DOI: 10.1097/01.NAJ.0000450430.97383.64. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

10.

Barendregt J, Doi S, Lee Y, Norman R, Vos T . Meta-analysis of prevalence. J Epidemiol Community Health. 2013; 67(11):974-8. DOI: 10.1136/jech-2013-203104. View

11.

Ioannidis J . Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008; 14(5):951-7. DOI: 10.1111/j.1365-2753.2008.00986.x. View

12.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

13.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

14.

Dean A, Crump L, Greter H, Schelling E, Zinsstag J . Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012; 6(10):e1865. PMC: 3493380. DOI: 10.1371/journal.pntd.0001865. View

15.

Mohammed B, Hamad A, Karom A . Brucellosis among animals and human contacts in eastern Sudan. Saudi Med J. 2001; 22(7):577-9. View

16.

Ntirandekura J, Matemba L, Kimera S, Muma J, Karimuribo E . Brucellosis and its associated risk factors to humans and domestic ruminants in Kagera Ecosystem, Tanzania. Afr Health Sci. 2021; 21(2):523-530. PMC: 8568260. DOI: 10.4314/ahs.v21i2.6. View

17.

Lucero N, Ayala S, Escobar G, Jacob N . Brucella isolated in humans and animals in Latin America from 1968 to 2006. Epidemiol Infect. 2007; 136(4):496-503. PMC: 2870831. DOI: 10.1017/S0950268807008795. View